MARKET ACCESS LANDSCAPE FOR BIOSIMILARS IN SWEDEN: AN UNTAPPED POTENTIAL?

被引：0

|

作者：

Olsson, K. ^{[1
]}

Carlqvist, P. ^{[1
]}

机构：

[1] Nord Market Access AB, Stockholm, Sweden

来源：

VALUE IN HEALTH | 2019年 / 22卷

关键词：

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

PBI74

引用

收藏

页码：S430 / S431

页数：2

相关论文

共 50 条

[31] Driving Improved Access to Biosimilars
Shanley, Agnes
BIOPHARM INTERNATIONAL, 2019, 32 (10) : 38 - +
[32] MORE ON UNTAPPED POTENTIAL
KELLER, AE
INFOSYSTEMS, 1984, 31 (06): : 136 - 136
[33] Untapped Potential of Dexmedetomidine
Kleiman, Amanda M.
Johnson, Ken B.
ANESTHESIA AND ANALGESIA, 2019, 129 (06): : 1450 - 1453
[34] BIOSIMILARS GAIN MARKET TRACTION
Thayer, Ann M.
CHEMICAL & ENGINEERING NEWS, 2015, 93 (43) : 28 - 29
[35] The untapped potential of retirement
Raven, John
PSYCHOLOGIST, 2013, 26 (04) : 238 - 239
[36] THE UNTAPPED POTENTIAL OF TRAINING
BJORK, R
DRUCKMAN, D
CHEMISTRY & INDUSTRY, 1994, (21) : 875 - 875
[37] The untapped potential of IT chargeback
Ross, JW
Vitale, MR
Beath, CM
MIS QUARTERLY, 1999, 23 (02) : 215 - 237
[38] BIOSIMILARS: ACCESSING THE UK MARKET
Das, P.
VALUE IN HEALTH, 2015, 18 (07) : A558 - A558
[39] POTENTIAL IMPACT OF THE BIOSIMILARS INTRODUCTION OF 3 ANTI-TNFS IN THE EUROPEAN MARKET
Psachoulia, E.
Martin-Rinconada, M. C.
Levysohn, A.
VALUE IN HEALTH, 2017, 20 (05) : A143 - A143
[40] Untapped Potential raise
Weisenfels, Michael
FLEISCHWIRTSCHAFT, 2012, 92 (06): : 3 - 3

← 1 2 3 4 5 →